Clinical Features and Outcomes of Dipeptidyl Peptidase-4 Inhibitor-Associated Bullous Pemphigoid (DPP4i-Associated BP) in Thai Patients

The use of dipeptidyl peptidase-4 inhibitors (DPP4i) appears to be associated with a small but significantly elevated risk of bullous pemphigoid (BP). Although the pathogenic mechanism of DPP4i-associated BP remains unclear, this adverse event is reported with multiple gliptins, suggesting a class e...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Case Rep Endocrinol
Главные авторы: Thewjitcharoen, Yotsapon, Wanothayaroj, Ekgaluck, Thammawiwat, Chattip, Porramatikul, Sriurai, Vorayingyong, Chuleekorn, Nakasatien, Soontaree, Krittiyawong, Sirinate, Chanprapaph, Kumutnart, Himathongkam, Thep
Формат: Artigo
Язык:Inglês
Опубликовано: Hindawi 2020
Предметы:
Case Series
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7569454/
https://ncbi.nlm.nih.gov/pubmed/33101737
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/8832643
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы